Pharmacology of adenosine receptors: the state of the art

PA Borea, S Gessi, S Merighi… - Physiological …, 2018 - journals.physiology.org
Adenosine is a ubiquitous endogenous autacoid whose effects are triggered through the
enrollment of four G protein-coupled receptors: A1, A2A, A2B, and A3. Due to the rapid …

Targeting adenosine in cancer immunotherapy to enhance T-cell function

S Vigano, D Alatzoglou, M Irving… - Frontiers in …, 2019 - frontiersin.org
T cells play a critical role in cancer control, but a range of potent immunosuppressive
mechanisms can be upregulated in the tumor microenvironment (TME) to abrogate their …

Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function

E Shifrut, J Carnevale, V Tobin, TL Roth, JM Woo… - Cell, 2018 - cell.com
Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based
functional studies in T cells could prioritize novel targets for drug development and improve …

Targets of immune escape mechanisms in cancer: basis for development and evolution of cancer immune checkpoint inhibitors

S Dutta, A Ganguly, K Chatterjee, S Spada… - Biology, 2023 - mdpi.com
Simple Summary The tumor immune escape mechanisms are key factors in cancer
progression and metastasis. They are an undeniable hurdle for successful cancer treatment …

[HTML][HTML] The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer

A Masjedi, V Hashemi, M Hojjat-Farsangi… - Biomedicine & …, 2018 - Elsevier
Despite remarkable improvements in cancer treatment approaches, breast cancer is still the
main cause of cancer-related death in women. Its principal cause is the resistance of the …

Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?

MH Kazemi, M Sadri, A Najafi, A Rahimi… - Frontiers in …, 2022 - frontiersin.org
Tumor-infiltrating lymphocytes (TILs), frontline soldiers of the adaptive immune system, are
recruited into the tumor site to fight against tumors. However, their small number and …

Targeting adenosine receptor signaling in cancer immunotherapy

K Sek, C Mølck, GD Stewart, L Kats, PK Darcy… - International journal of …, 2018 - mdpi.com
The immune system plays a major role in the surveillance and control of malignant cells,
with the presence of tumor infiltrating lymphocytes (TILs) correlating with better patient …

Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them

KJ Habashy, R Mansour, C Moussalem… - British journal of …, 2022 - nature.com
Glioblastoma is the most common and aggressive primary malignant brain tumour. The
prognosis of patients with glioblastoma is poor, and their overall survival averages at 1 year …

Cancer biology and molecular genetics of A3 adenosine receptor

C Mazziotta, JC Rotondo, C Lanzillotti, G Campione… - Oncogene, 2022 - nature.com
Abstract A3 adenosine receptor (A3AR) is a cell membrane protein, which has been found to
be overexpressed in a large number of cancer types. This receptor plays an important role in …

CD73 as a potential opportunity for cancer immunotherapy

G Ghalamfarsa, MH Kazemi… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Cancer cells apply various mechanisms to induce and enhance immune
escape. The complex network of immune-response modulating factors in the tumor …